Offering the highest level of care, including neuro-intensive care units, complex neurosurgical interventions, and advanced brain and blood-vessel imaging, Cedars-Sinai has been designated as Comprehensive Stroke Center by The Joint Commission.This Advanced Certification for Comprehensive Stroke Centers recognizes the significant resources in staff and training that comprehensive stroke centers must have to treat complex stroke cases. Cedars-Sinai was proud to be among the first 5 in the nation to receive this prestigious and rigorous designation and the first Comprehensive Stroke Center in Southern California.
At the Cedars-Sinai Stroke Program, the care given to persons who have had a stroke is measured against the standards created in the Get With the Guidelines program sponsored by the American Heart Association and the American Stroke Association. Currently, 2,825 hospitals are participating in the Get With the Guidelines program. They have contributed information on 4,582,815patients in 2016, including the 1,094 discharges from Cedars-Sinai.
To view Cedars-Sinai performance on the Get With the Guidelines measures, click on the links below.
- Types of Strokes Treated at Cedars-Sinai
- Timely Administration of the Drug tPA
- Stroke Patient Education
- Rehabilitation Plans Following a Stroke
- Mortality Rate Following a Stroke
- Discharge After Treatment for a Stroke
- Functional Independence Improvements Following Treatment for a Stroke During Inpatient Rehabilitation
Quality of care information is also collected by The Joint Commission. View Cedars-Sinai performance on the Stroke Care Core Measures.
Profile of Patients Receiving Stroke Treatment at Cedars-Sinai
The chart below compares the type of patients treated at Cedars-Sinai with all patients reported by hospitals nationally participating in the Get With the Guidelines program. The average age of patients treated at Cedars-Sinai is 70, which also is the national program's average.
Patients treated at Cedars-Sinai had one of the following types of strokes:
- Hemorrhagic, where blood leaks from a blood vessel into brain tissue. This type of stroke can take two forms. A subarachnoid hemorrhage where a blood vessel just outside the brain ruptures. The area of the skull surrounding the brain (the subarachnoid space) quickly fills with blood. The second type is an intracerebral hemorrhage, in which there is bleeding inside the brain that causes a build up of pressure and damage to brain cells.
- Ischemic, where a blood clot shuts off the flow of blood to parts of the brain
- Transient ischemic attacks
The chart below compares the percentage of people treated for each type of stroke at Cedars-Sinai and nationally.
Tissue plasminogen activator (tPA) is a powerful drug used to break up blood clots that cause ischemic strokes. The drug is usually given through a vein in the arm. To be effective, the drug must be given within four-and-a-half hours after a stroke occurs. Not all people having ischemic strokes benefit from tPA. The drug has certain side effects that a doctor must consider before deciding whether tPA is the best treatment for a stroke patient.
A higher number is better.
Patient education following a stroke can help prevent future strokes. The chart below compares how many Cedars-Sinai patients received education following a stroke compared to hospitals nationally.
A higher number is better.
A stroke can cause damage to the brain that makes it difficult for a person to return to his or her normal daily activities. Rehabilitation after a stroke can help a person live with any remaining effects of a stroke. It can also help the brain recover more fully. The chart below shows the percentage of stroke patients treated at Cedars-Sinai for whom a rehabilitation plan was considered. These data are compared to hospitals nationally.
A higher number is better.
The graph below shows the percentage of patients who died in the hospital after being admitted following a stroke. The Cedars-Sinai mortality rate for both hemorrhagic and ischemic (non-hemorrhagic) strokes was lower in 2016 for than the average for other hospitals participating in the Get With the Guidelines program.
A lower number is better.
The following chart shows the percentage of patients who were discharged to their own homes (with and without home health care), inpatient rehabilitation, skilled nursing facilities or other places.
Functional Independence Improvements Following Treatment for a Stroke During Inpatient Rehabilitation
A patient's ability to do activities of daily living without help is measured by a tool called the Functional Improvement Measure™ (FIM). Using this tool, rehabilitation specialists working with patients can measure their progress from admission through discharge.
The Uniform Data System for Medical Rehabilitation is the national benchmark providing a way to document functional severity and the results of medical rehabilitation. Through the use of the Functional Independence Measure, clinicians follow changes in functional status from admission to discharge. The FIM contains 18 items that assess severity of disability and level of functional independence on a 7 point scale.
Ratings are performed in the areas of self-care, sphincter control, mobility, communication, and social cognition. Ratings are established by the interdisciplinary team at admission to inpatient rehabilitation and at discharge from inpatient rehabilitation. Outcomes are measured by taking the numeric difference between the admission FIM and the discharge FIM. FIM scores range from 18 (dependent) to 126 (independent).
The chart below shows the average functional independence score of patients admitted to Cedars-Sinai following a stroke, the improvement in FIM score during treatment and their FIM score at discharge. The data reflects care at Cedars-Sinai Medical Center only. Rehab services for Cedars-Sinai patients starting August 2016 were provided at the California Rehabilitation Institute, a joint venture between Cedars-Sinai and UCLA. Data for August-December 2016 will be presented when available.
The Get With the Guidelines aggregate data report was generated using the OutcomeTM PMT system. Copy or distribution of this aggregate data is prohibited without the prior written consent of the American Heart Association and Outcome Services Inc. The data reported here is from the report run in March 2017 reflecting 2016 data.